What is the initial step to diagnose celiac disease using the ICD 10 (International Classification of Diseases, 10th Revision) code for ordering a celiac panel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Coding for Celiac Panel Testing

The appropriate ICD-10 code for ordering a celiac panel depends on the clinical presentation: use K90.0 for suspected or confirmed celiac disease, Z71.3 for dietary counseling and surveillance in established disease, or symptom-specific codes (e.g., K59.1 for chronic diarrhea, D50.9 for iron deficiency anemia) when celiac disease is being ruled out as part of a differential diagnosis. 1

Primary ICD-10 Codes for Celiac Testing

For Suspected Celiac Disease

  • K90.0 - Celiac disease (celiac sprue, gluten-sensitive enteropathy, nontropical sprue) is the most direct code when celiac disease is clinically suspected based on symptoms or risk factors 1
  • This code is appropriate even before diagnostic confirmation, as it encompasses "suspected celiac disease" in clinical practice 2, 1

For Screening High-Risk Populations

  • Z83.79 - Family history of other diseases of the digestive system, used when screening first-degree relatives of patients with celiac disease 1, 3
  • E10.9 - Type 1 diabetes mellitus without complications, when screening diabetic patients for celiac disease 1, 3
  • Q90.9 - Down syndrome, unspecified, when screening patients with Down syndrome 1, 4

For Symptom-Based Testing

  • K59.1 - Chronic diarrhea, when evaluating unexplained chronic diarrhea 2, 1
  • D50.9 - Iron deficiency anemia, unspecified, when celiac disease is present in 2-6% of patients with unexplained iron deficiency 1, 4
  • R19.7 - Diarrhea, unspecified, for acute or subacute presentations 2
  • R10.9 - Unspecified abdominal pain, when abdominal pain is the primary complaint 2
  • R63.4 - Abnormal weight loss, for unexplained weight loss 2
  • K90.9 - Intestinal malabsorption, unspecified, when malabsorption is suspected 2

Components of the Celiac Panel to Order

Initial Screening Tests

  • IgA tissue transglutaminase antibody (tTG-IgA) is the single best serologic test with sensitivity of 90-96% and specificity >95% 2, 1, 4
  • Total IgA level must be measured concurrently to rule out IgA deficiency, which occurs in 1-3% of celiac patients and causes falsely negative IgA-based tests 2, 1

Confirmatory and Supplemental Tests

  • IgA endomysial antibody (EMA-IgA) should be performed when tTG-IgA is >10× upper limit of normal, as the combination approaches 100% positive predictive value 2, 1
  • IgG deamidated gliadin peptide (DGP-IgG) or IgG tTG should be ordered if IgA deficiency is detected 2, 1
  • IgG-based tests are markedly less accurate in patients with normal IgA levels and should not be used in that setting 1

Critical Testing Requirements

Patient Must Be on Gluten-Containing Diet

  • Testing must be performed while the patient consumes at least 10g of gluten daily for 6-8 weeks 2, 1
  • Reduction or avoidance of gluten prior to diagnostic testing reduces sensitivity of both serology and biopsy 2, 1
  • Patients who have already started a gluten-free diet should resume normal diet with three slices of wheat bread daily for 1-3 months before repeat testing 2, 1

Biopsy Confirmation Required

  • Intestinal biopsy remains the gold standard for diagnosis in adults, even with strongly positive serology 2, 1
  • Multiple biopsy specimens (ideally 6 total: 1-2 from duodenal bulb and at least 4 from second part of duodenum) should be obtained 1, 3
  • The exception is children with tTG-IgA ≥10× upper limit of normal, positive EMA-IgA, and positive HLA-DQ2/DQ8, who may avoid biopsy per recent pediatric guidelines 1

Additional Codes for Associated Conditions

When Screening for Complications

  • M81.0 - Age-related osteoporosis without current pathological fracture, for premature osteoporosis screening 1, 4
  • K74.60 - Unspecified cirrhosis of liver, for unexplained liver transaminase elevations 1, 4
  • E03.9 - Hypothyroidism, unspecified, when screening for autoimmune thyroid disease 1, 4

Common Pitfalls to Avoid

Testing Errors

  • Never rely solely on IgG tTG antibody in the absence of IgA deficiency, as it is not specific 2, 1
  • IgA and IgG antigliadin antibodies (non-deamidated) confer no additional diagnostic benefit in adults and should not be ordered 2, 5
  • Different tTG-IgA assays have varying sensitivity, so specify the threshold used (typically >10× upper limit of normal for high specificity) 2, 1

Documentation Requirements

  • Document the clinical indication clearly in the medical record to support medical necessity 1
  • Note whether the patient is on a gluten-containing diet at the time of testing 2, 1
  • For screening high-risk populations, document the specific risk factor (family history, type 1 diabetes, etc.) 1, 3

Insurance Considerations

  • Most insurers require documentation of symptoms, risk factors, or family history to approve celiac testing 1
  • Using symptom-specific codes (diarrhea, anemia, weight loss) rather than screening codes may improve authorization rates when appropriate 1
  • HLA-DQ2/DQ8 testing has limited diagnostic role and is primarily useful for its negative predictive value when celiac disease is strongly suspected despite negative serology 2, 1, 4

References

Guideline

Celiac Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Celiac Disease: Ten Things That Every Gastroenterologist Should Know.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015

Guideline

Celiac Disease Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.